Why immunotherapy works well for some cancer patients, but not others

Yale researchers have found that a mechanism for faulty DNA repair in tumors is a key factor in determining whether patients respond to immunotherapy.

Related Keywords

United States ,American ,Bryan Chow ,Alessandro Santin ,American Association For Cancer Research ,Systems Biology Institute ,Yale School Of Medicine ,Yale Department Of Genetics ,Yale School ,Cancer Discovery ,American Association ,Cancer Research ,Systems Biology ,Eric Song ,Yale University ,News ,Pa ,Pac ,Press Releases ,